News for Healthier Living

Common Obesity Medications Lead to Higher Muscle Loss Than Other Weight Loss Interventions, Review Finds

A systematic review of clinical trials found that adults treated with incretin-based obesity medications, like semaglutide and tirzepatide, not only lose significant body fat but also tend to have more muscle-related loss than with other weight loss interventions.

April 17, 2026


May 1 2026

April 30 2026

April 29 2026

April 28 2026

April 27 2026

April 26 2026

April 25 2026

April 24 2026

April 23 2026

April 22 2026

April 21 2026

April 20 2026

April 19 2026

April 18 2026